Patents by Inventor Steven NEIBART

Steven NEIBART has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS
    Publication number: 20180042941
    Abstract: The present disclosure relates to the compound having the following formula (I): which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use for the treatment of castration resistant or hormone-refractory metastatic prostate cancer in patients not at risk of developing gastrointestinal disorders chosen from the group consisting of: gastrointestinal bleeding and perforation, gastritis, enterocolitis, neutropenic enterocolitis, colitis, intestinal obstruction, and ileus.
    Type: Application
    Filed: December 14, 2016
    Publication date: February 15, 2018
    Inventor: Steven NEIBART
  • CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS
    Publication number: 20150374717
    Abstract: The present disclosure relates to the compound having the following formula (I): which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use for the treatment of castration resistant or hormone-refractory metastatic prostate cancer in patients not at risk of developing gastrointestinal disorders chosen from the group consisting of: gastrointestinal bleeding and perforation, gastritis, enterocolitis, neutropenic enterocolitis, colitis, intestinal obstruction, and ileus.
    Type: Application
    Filed: September 3, 2015
    Publication date: December 31, 2015
    Inventor: Steven NEIBART